LTFS
ANAC

Ladenburg Thalmann Financial Services’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,220
Closed -$65K – 5103
2016
Q1 		$65K Sell
1,220
-32
-3% -$2.36K ﹤0.01% 2397
2015
Q4 		$141K Sell
1,252
-2,799
-69% -$308K ﹤0.01% 1821
2015
Q3 		$477K Buy
4,051
+3
+0.1% +$392 0.01% 992
2015
Q2 		$314K Buy
4,048
+548
+16% +$35.9K 0.01% 1302
2015
Q1 		$202K Buy
3,500
+750
+27% +$31.8K ﹤0.01% 1568
2014
Q4 		$89K Hold
2,750
– – ﹤0.01% 1972
2014
Q3 		$67K Hold
2,750
– – ﹤0.01% 1848
2014
Q2 		$49K Hold
2,750
– – ﹤0.01% 2076
2014
Q1 		$55K Buy
2,750
+250
+10% +$4.85K ﹤0.01% 1901
2013
Q4 		$42K Buy
2,500
+500
+25% +$6.92K ﹤0.01% 2047
2013
Q3 		$21K Buy
+2,000
New +$17.5K ﹤0.01% 2437

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ANAC Position: Q2 2016 in Review

Ladenburg Thalmann Financial Services sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 1,220 shares — an estimated $65K sold.

Ladenburg Thalmann Financial Services first reported a position in ANAC in Q3 2013 and held it in 11 quarters. The position peaked at $477K in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Ladenburg Thalmann Financial Services reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 1,220 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $65K.
  • Ladenburg Thalmann Financial Services first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 11 quarters.
  • Ladenburg Thalmann Financial Services's ANACOR PHARMACEUTICALS INC COM position peaked at $477K in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2016, filed 15 Aug 2016.